Health Care & Life Sciences » Pharmaceuticals | Molecular Pharmacology

Molecular Pharmacology

Molecular Pharmacology
Stock Exchange Other OTC
EPS
$0
Market Cap
$206.38 K
Shares Outstanding
111.55 M
Public Float
23.55 M

Profile

Address
Drug Discovery Research Centre
Perth Western Australia (WA) 6007
Australia
Employees -
Website -
Updated 07/08/2019
Molecular Pharmacology (USA) Ltd. engages in the development of pharmaceutical products. The firm operates through the Australia and the Unites States geographical segments. It also commercializes an analgesic and anti-inflammatory drug under the Tripeptofen brand.

Financials

View All
Created with Highcharts 5.0.14Molecular PharmacologyNet Income. Fiscal year is July-June. All values USD Thousands.11711712112117917920920911611620102011201220132014050100150200250

Jeffrey David Edwards
President, Chief Executive Officer, CFO & Director
Jeffrey David Edwards
President, Chief Executive Officer, CFO & Director